Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H28O3 |
| Molecular Weight | 364.4773 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C5=CC(=O)C=C[C@]35C)[C@@H]1[C@@H]6C[C@@H]6[C@@]27CCC(=O)O7
InChI
InChIKey=NZUIUYWHFPQZBH-HXCATZOESA-N
InChI=1S/C24H28O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h3,6,9,13-16,18,20-21H,4-5,7-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1
Spirorenone is an androstadienone derivative patented by Schering A.-G as a highly effective aldosterone antagonist. Spirorenone is 8.6 times as potent as spironolactone, but showed a lower affinity for the mineralocorticoid receptors. In phase I clinical trials Spirorenone was absorbed with a half-life of 20-30 min, achieving maximum concentrations of about 100 ng/ml (10 mg) and 260 ng/ml (40 mg) after 1-2 h. Disposition of the parent drug was biphasic with half-lives of 50-60 min (distribution) and 5-6 h (elimination). Neither significant accumulation nor enzyme induction was observed after prolonged treatment.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pharmacokinetics of the new aldosterone antagonist, spirorenone, in healthy volunteers after single and repeated daily doses. | 1983 |
|
| Determination of plasma levels of spirorenone, a new aldosterone antagonist, and one of its metabolites by high-performance liquid chromatography. | 1982-06-11 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6628506
10 and 40 mg for 14 days
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C101255
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C035143
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
PRIMARY | |||
|
4986
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
PRIMARY | |||
|
C152420
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
PRIMARY | |||
|
DTXSID501024537
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
PRIMARY | |||
|
100000083829
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
PRIMARY | |||
|
B8TEV07170
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
PRIMARY | |||
|
277-770-1
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
PRIMARY | |||
|
SUB10633MIG
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
PRIMARY | |||
|
74220-07-8
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
PRIMARY | |||
|
68923
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
PRIMARY | |||
|
Spirorenone
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107584
Created by
admin on Wed Apr 02 07:40:41 GMT 2025 , Edited by admin on Wed Apr 02 07:40:41 GMT 2025
|
PRIMARY |
ACTIVE MOIETY